Financhill
Sell
50

A Quote, Financials, Valuation and Earnings

Last price:
$127.53
Seasonality move :
-0.63%
Day range:
$128.63 - $131.43
52-week range:
$96.43 - $160.27
Dividend yield:
0.77%
P/E ratio:
28.36x
P/S ratio:
5.32x
P/B ratio:
5.45x
Volume:
1.9M
Avg. volume:
1.8M
1-year change:
-12.23%
Market cap:
$36.7B
Revenue:
$6.9B
EPS (TTM):
$4.57

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
A
Agilent Technologies, Inc.
$1.8B $1.37 7.56% 84.63% $169.67
AVTR
Avantor, Inc.
$1.6B $0.22 -0.43% 114.85% $13.04
AZTA
Azenta, Inc.
$147.1M $0.13 3.42% 86.12% $40.80
BIO
Bio-Rad Laboratories, Inc.
$694.6M $2.71 4.07% -91.72% $348.00
BRKR
Bruker Corp.
$964.6M $0.66 -0.22% 257.45% $54.43
RVTY
Revvity, Inc.
$763.1M $1.58 5.95% 195.76% $119.56
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
A
Agilent Technologies, Inc.
$129.58 $169.67 $36.7B 28.36x $0.26 0.77% 5.32x
AVTR
Avantor, Inc.
$11.26 $13.04 $7.7B 10.97x $0.00 0% 1.17x
AZTA
Azenta, Inc.
$28.72 $40.80 $1.3B -- $0.00 0% 2.21x
BIO
Bio-Rad Laboratories, Inc.
$301.50 $348.00 $8.1B 27.23x $0.00 0% 3.25x
BRKR
Bruker Corp.
$41.93 $54.43 $6.4B 77.08x $0.05 0.48% 1.85x
RVTY
Revvity, Inc.
$101.59 $119.56 $11.5B 49.19x $0.07 0.28% 4.15x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
A
Agilent Technologies, Inc.
34.45% 1.742 8.55% 1.40x
AVTR
Avantor, Inc.
40.92% 1.095 45.33% 0.90x
AZTA
Azenta, Inc.
3.08% 2.664 3.56% 2.22x
BIO
Bio-Rad Laboratories, Inc.
17.16% 1.271 18.45% 3.62x
BRKR
Bruker Corp.
45.23% 1.053 40.19% 0.76x
RVTY
Revvity, Inc.
31.72% 0.868 30.71% 1.25x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
A
Agilent Technologies, Inc.
$977M $443M 13.42% 20.9% 23.8% $452M
AVTR
Avantor, Inc.
$526.5M $138.4M -0.81% -1.4% 8.52% $171.7M
AZTA
Azenta, Inc.
$63.7M -$4.9M 1.64% 1.7% -3.28% $14.7M
BIO
Bio-Rad Laboratories, Inc.
$342.8M $66.4M -8.14% -9.77% 10.17% $89.2M
BRKR
Bruker Corp.
$399.6M $55.2M -0.56% -1.2% 6.42% -$54.1M
RVTY
Revvity, Inc.
$338.1M $111.7M 2.21% 3.2% 14.47% $163.1M

Agilent Technologies, Inc. vs. Competitors

  • Which has Higher Returns A or AVTR?

    Avantor, Inc. has a net margin of 23.32% compared to Agilent Technologies, Inc.'s net margin of -43.84%. Agilent Technologies, Inc.'s return on equity of 20.9% beat Avantor, Inc.'s return on equity of -1.4%.

    Company Gross Margin Earnings Per Share Invested Capital
    A
    Agilent Technologies, Inc.
    52.5% $1.53 $10.3B
    AVTR
    Avantor, Inc.
    32.42% -$1.04 $9.4B
  • What do Analysts Say About A or AVTR?

    Agilent Technologies, Inc. has a consensus price target of $169.67, signalling upside risk potential of 30.94%. On the other hand Avantor, Inc. has an analysts' consensus of $13.04 which suggests that it could grow by 15.77%. Given that Agilent Technologies, Inc. has higher upside potential than Avantor, Inc., analysts believe Agilent Technologies, Inc. is more attractive than Avantor, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    A
    Agilent Technologies, Inc.
    11 6 0
    AVTR
    Avantor, Inc.
    3 14 1
  • Is A or AVTR More Risky?

    Agilent Technologies, Inc. has a beta of 1.298, which suggesting that the stock is 29.765% more volatile than S&P 500. In comparison Avantor, Inc. has a beta of 0.941, suggesting its less volatile than the S&P 500 by 5.874%.

  • Which is a Better Dividend Stock A or AVTR?

    Agilent Technologies, Inc. has a quarterly dividend of $0.26 per share corresponding to a yield of 0.77%. Avantor, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilent Technologies, Inc. pays 21.7% of its earnings as a dividend. Avantor, Inc. pays out -- of its earnings as a dividend. Agilent Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios A or AVTR?

    Agilent Technologies, Inc. quarterly revenues are $1.9B, which are larger than Avantor, Inc. quarterly revenues of $1.6B. Agilent Technologies, Inc.'s net income of $434M is higher than Avantor, Inc.'s net income of -$711.8M. Notably, Agilent Technologies, Inc.'s price-to-earnings ratio is 28.36x while Avantor, Inc.'s PE ratio is 10.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies, Inc. is 5.32x versus 1.17x for Avantor, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    A
    Agilent Technologies, Inc.
    5.32x 28.36x $1.9B $434M
    AVTR
    Avantor, Inc.
    1.17x 10.97x $1.6B -$711.8M
  • Which has Higher Returns A or AZTA?

    Azenta, Inc. has a net margin of 23.32% compared to Agilent Technologies, Inc.'s net margin of -3.49%. Agilent Technologies, Inc.'s return on equity of 20.9% beat Azenta, Inc.'s return on equity of 1.7%.

    Company Gross Margin Earnings Per Share Invested Capital
    A
    Agilent Technologies, Inc.
    52.5% $1.53 $10.3B
    AZTA
    Azenta, Inc.
    42.86% -$0.34 $1.8B
  • What do Analysts Say About A or AZTA?

    Agilent Technologies, Inc. has a consensus price target of $169.67, signalling upside risk potential of 30.94%. On the other hand Azenta, Inc. has an analysts' consensus of $40.80 which suggests that it could grow by 42.06%. Given that Azenta, Inc. has higher upside potential than Agilent Technologies, Inc., analysts believe Azenta, Inc. is more attractive than Agilent Technologies, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    A
    Agilent Technologies, Inc.
    11 6 0
    AZTA
    Azenta, Inc.
    2 3 0
  • Is A or AZTA More Risky?

    Agilent Technologies, Inc. has a beta of 1.298, which suggesting that the stock is 29.765% more volatile than S&P 500. In comparison Azenta, Inc. has a beta of 1.349, suggesting its more volatile than the S&P 500 by 34.927%.

  • Which is a Better Dividend Stock A or AZTA?

    Agilent Technologies, Inc. has a quarterly dividend of $0.26 per share corresponding to a yield of 0.77%. Azenta, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilent Technologies, Inc. pays 21.7% of its earnings as a dividend. Azenta, Inc. pays out -- of its earnings as a dividend. Agilent Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios A or AZTA?

    Agilent Technologies, Inc. quarterly revenues are $1.9B, which are larger than Azenta, Inc. quarterly revenues of $148.6M. Agilent Technologies, Inc.'s net income of $434M is higher than Azenta, Inc.'s net income of -$5.2M. Notably, Agilent Technologies, Inc.'s price-to-earnings ratio is 28.36x while Azenta, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies, Inc. is 5.32x versus 2.21x for Azenta, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    A
    Agilent Technologies, Inc.
    5.32x 28.36x $1.9B $434M
    AZTA
    Azenta, Inc.
    2.21x -- $148.6M -$5.2M
  • Which has Higher Returns A or BIO?

    Bio-Rad Laboratories, Inc. has a net margin of 23.32% compared to Agilent Technologies, Inc.'s net margin of -52.36%. Agilent Technologies, Inc.'s return on equity of 20.9% beat Bio-Rad Laboratories, Inc.'s return on equity of -9.77%.

    Company Gross Margin Earnings Per Share Invested Capital
    A
    Agilent Technologies, Inc.
    52.5% $1.53 $10.3B
    BIO
    Bio-Rad Laboratories, Inc.
    52.5% -$12.70 $8.1B
  • What do Analysts Say About A or BIO?

    Agilent Technologies, Inc. has a consensus price target of $169.67, signalling upside risk potential of 30.94%. On the other hand Bio-Rad Laboratories, Inc. has an analysts' consensus of $348.00 which suggests that it could grow by 15.42%. Given that Agilent Technologies, Inc. has higher upside potential than Bio-Rad Laboratories, Inc., analysts believe Agilent Technologies, Inc. is more attractive than Bio-Rad Laboratories, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    A
    Agilent Technologies, Inc.
    11 6 0
    BIO
    Bio-Rad Laboratories, Inc.
    2 3 0
  • Is A or BIO More Risky?

    Agilent Technologies, Inc. has a beta of 1.298, which suggesting that the stock is 29.765% more volatile than S&P 500. In comparison Bio-Rad Laboratories, Inc. has a beta of 1.180, suggesting its more volatile than the S&P 500 by 18.018%.

  • Which is a Better Dividend Stock A or BIO?

    Agilent Technologies, Inc. has a quarterly dividend of $0.26 per share corresponding to a yield of 0.77%. Bio-Rad Laboratories, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilent Technologies, Inc. pays 21.7% of its earnings as a dividend. Bio-Rad Laboratories, Inc. pays out -- of its earnings as a dividend. Agilent Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios A or BIO?

    Agilent Technologies, Inc. quarterly revenues are $1.9B, which are larger than Bio-Rad Laboratories, Inc. quarterly revenues of $653M. Agilent Technologies, Inc.'s net income of $434M is higher than Bio-Rad Laboratories, Inc.'s net income of -$341.9M. Notably, Agilent Technologies, Inc.'s price-to-earnings ratio is 28.36x while Bio-Rad Laboratories, Inc.'s PE ratio is 27.23x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies, Inc. is 5.32x versus 3.25x for Bio-Rad Laboratories, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    A
    Agilent Technologies, Inc.
    5.32x 28.36x $1.9B $434M
    BIO
    Bio-Rad Laboratories, Inc.
    3.25x 27.23x $653M -$341.9M
  • Which has Higher Returns A or BRKR?

    Bruker Corp. has a net margin of 23.32% compared to Agilent Technologies, Inc.'s net margin of -6.8%. Agilent Technologies, Inc.'s return on equity of 20.9% beat Bruker Corp.'s return on equity of -1.2%.

    Company Gross Margin Earnings Per Share Invested Capital
    A
    Agilent Technologies, Inc.
    52.5% $1.53 $10.3B
    BRKR
    Bruker Corp.
    46.44% -$0.41 $4.5B
  • What do Analysts Say About A or BRKR?

    Agilent Technologies, Inc. has a consensus price target of $169.67, signalling upside risk potential of 30.94%. On the other hand Bruker Corp. has an analysts' consensus of $54.43 which suggests that it could grow by 29.81%. Given that Agilent Technologies, Inc. has higher upside potential than Bruker Corp., analysts believe Agilent Technologies, Inc. is more attractive than Bruker Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    A
    Agilent Technologies, Inc.
    11 6 0
    BRKR
    Bruker Corp.
    7 5 1
  • Is A or BRKR More Risky?

    Agilent Technologies, Inc. has a beta of 1.298, which suggesting that the stock is 29.765% more volatile than S&P 500. In comparison Bruker Corp. has a beta of 1.186, suggesting its more volatile than the S&P 500 by 18.621%.

  • Which is a Better Dividend Stock A or BRKR?

    Agilent Technologies, Inc. has a quarterly dividend of $0.26 per share corresponding to a yield of 0.77%. Bruker Corp. offers a yield of 0.48% to investors and pays a quarterly dividend of $0.05 per share. Agilent Technologies, Inc. pays 21.7% of its earnings as a dividend. Bruker Corp. pays out 26.44% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios A or BRKR?

    Agilent Technologies, Inc. quarterly revenues are $1.9B, which are larger than Bruker Corp. quarterly revenues of $860.5M. Agilent Technologies, Inc.'s net income of $434M is higher than Bruker Corp.'s net income of -$58.5M. Notably, Agilent Technologies, Inc.'s price-to-earnings ratio is 28.36x while Bruker Corp.'s PE ratio is 77.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies, Inc. is 5.32x versus 1.85x for Bruker Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    A
    Agilent Technologies, Inc.
    5.32x 28.36x $1.9B $434M
    BRKR
    Bruker Corp.
    1.85x 77.08x $860.5M -$58.5M
  • Which has Higher Returns A or RVTY?

    Revvity, Inc. has a net margin of 23.32% compared to Agilent Technologies, Inc.'s net margin of 12.41%. Agilent Technologies, Inc.'s return on equity of 20.9% beat Revvity, Inc.'s return on equity of 3.2%.

    Company Gross Margin Earnings Per Share Invested Capital
    A
    Agilent Technologies, Inc.
    52.5% $1.53 $10.3B
    RVTY
    Revvity, Inc.
    43.8% $0.85 $10.6B
  • What do Analysts Say About A or RVTY?

    Agilent Technologies, Inc. has a consensus price target of $169.67, signalling upside risk potential of 30.94%. On the other hand Revvity, Inc. has an analysts' consensus of $119.56 which suggests that it could grow by 17.69%. Given that Agilent Technologies, Inc. has higher upside potential than Revvity, Inc., analysts believe Agilent Technologies, Inc. is more attractive than Revvity, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    A
    Agilent Technologies, Inc.
    11 6 0
    RVTY
    Revvity, Inc.
    8 8 0
  • Is A or RVTY More Risky?

    Agilent Technologies, Inc. has a beta of 1.298, which suggesting that the stock is 29.765% more volatile than S&P 500. In comparison Revvity, Inc. has a beta of 1.066, suggesting its more volatile than the S&P 500 by 6.609%.

  • Which is a Better Dividend Stock A or RVTY?

    Agilent Technologies, Inc. has a quarterly dividend of $0.26 per share corresponding to a yield of 0.77%. Revvity, Inc. offers a yield of 0.28% to investors and pays a quarterly dividend of $0.07 per share. Agilent Technologies, Inc. pays 21.7% of its earnings as a dividend. Revvity, Inc. pays out 13.61% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios A or RVTY?

    Agilent Technologies, Inc. quarterly revenues are $1.9B, which are larger than Revvity, Inc. quarterly revenues of $772.1M. Agilent Technologies, Inc.'s net income of $434M is higher than Revvity, Inc.'s net income of $95.8M. Notably, Agilent Technologies, Inc.'s price-to-earnings ratio is 28.36x while Revvity, Inc.'s PE ratio is 49.19x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies, Inc. is 5.32x versus 4.15x for Revvity, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    A
    Agilent Technologies, Inc.
    5.32x 28.36x $1.9B $434M
    RVTY
    Revvity, Inc.
    4.15x 49.19x $772.1M $95.8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
53
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 30x

Alerts

Sell
40
BILL alert for Feb 9

Bill Holdings, Inc. [BILL] is up 3.7% over the past day.

Buy
75
PRLB alert for Feb 9

Proto Labs, Inc. [PRLB] is down 2.16% over the past day.

Sell
30
MSTR alert for Feb 9

Strategy, Inc. [MSTR] is up 2.59% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock